Clinical Research is a key principal of the NHS . The Alverton practice has been performing clinical research since 1996 and Dr John Ryan has much experience in phase II, III and IV studies in a wide range of indications.
As a patient at the practice you may on occasions be approached to participate in a clinical trial. Your participation in a clinical trial is going to be greatly appreciated and make a difference, however, should you choose not to after being approached, we apologise in advance and thank you for giving it some consideration.
The practice often uses electronic records to perform searches for specific conditions and you may be identified as a potential study candidate by this method. The information always remains on site and is completely confidential.
The aim of a clinical trial is to provide evidence to know which treatments work best, without trials this is not possible and remember many treatments that you are receiving will have been tested in clinical trials. This is the only way we can improve the health of the nation.
Most Clinical trials require the collection and storage of personal data, so just to reassure you, all identifiable study data such as signed consent forms are stored in a secure place. Your confidentiality is also ensured by the use of initials and numbers only on research material. Any other documentation that is required to leave the practice is anonymised to remove any subject identifiers
Our practice is also part of The Cornwall Clinical Researcg Group that consists of a group of hight experienced and enthuastic General Practitioner Investigators who work with a broad range of pharmaceutical companies in Europe and the USA. We are based in five General practice Surgeries across Cornwall and Plymouth with access through advertising to almost the entire regions population of 400'000 patients. The group was formed nearly 20 years ago.
We pride ourselves on:
- Quality Research
- Delivery On Time
- High Ethical Standards
- GCP accredited
- Excellent Communication between centres
Our healthy relationship with the pharmaceutical industry and the group’s record over the last twenty years demonstrates our ability to continually deliver.